INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('AHR', 'STOCK', 'American Healthcare REIT, Inc.', 'NYQ', 'Real Estate', 'REIT - Healthcare Facilities', 'A American HEALTHCARE REIT, Inc. É uma confiança de investimento imobiliário que adquire, possui e opera um portfólio diversificado de imóveis de saúde clínica, com foco principalmente em residências seniores, instalações de enfermagem especializadas, edifícios médicos ambulatoriais (OM) e outras instalações relacionadas à saúde em todos os Estados Unidos, Reino Unido e Ilha de Man Possui e opera seus campi de saúde sênior integrados e propriedades operacionais de habitação sênior (loja). Seus segmentos incluem campus de saúde sênior integrados, OM, LOJA e propriedades alugadas triple-net. Seus edifícios OM são alugados a vários inquilinos sob arrendamentos separados. Seus campi de saúde sênior integrados fornecem uma gama de vida independente, vida assistida, cuidados de memória, serviços de enfermagem qualificados e negócios auxiliares. O seu segmento de propriedades alugadas triplas inclui habitação sénior, instalações de enfermagem especializadas e hospitais. Seu segmento DE loja i', 'Irvine, CA, United States', 114);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('AUB', 'STOCK', 'Atlantic Union Bankshares Corporation', 'NYQ', 'Financial Services', 'Banks - Regional', 'Atlantic Union Bankshares Corporation is the holding company for Atlantic Union Bank (the Bank), which provides banking and related financial products and services to consumers and businesses. The Bank has branches and ATMs located in Virginia, Maryland and North Carolina. It operates through two segments: Wholesale Banking and Consumer Banking. Its Wholesale Banking segment provides loan, leasing, and deposit services, as well as treasury management and capital market services to wholesale customers primarily throughout Virginia, Maryland, North Carolina, and South Carolina. These customers include commercial and industrial customers. This segment also includes its equipment finance subsidiary and its wealth management business. Its Consumer Banking segment provides loan and deposit services to consumers and small businesses throughout Virginia, Maryland, and North Carolina. Consumer Banking includes the home loan division and investment management, and advisory services businesses.', 'Glen Allen, VA, United States', 3160);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('ALC', 'STOCK', 'Alcon Inc.', 'NYQ', 'Healthcare', 'Medical Instruments & Supplies', 'A Alcon AG é uma empresa de oftalmologia sediada na Suíça. A Companhia pesquisa, desenvolve, fabrica, distribui e vende um conjunto completo de produtos para cuidados com os olhos em dois negócios principais: Cirúrgico e Vision Care. O negócio Cirúrgico da Companhia é focado em produtos oftálmicos para cirurgia de catarata, cirurgia vitreorretiniana, cirurgia refrativa a laser e cirurgia de glaucoma. O portfólio cirúrgico inclui implantáveis, consumíveis e equipamentos cirúrgicos necessários para esses procedimentos e atende às necessidades do cirurgião oftalmologista de ponta a ponta. O negócio Vision Care da Companhia compreende lentes de contato diárias descartáveis, reutilizáveis e que melhoram as cores e um portfólio de produtos de saúde ocular, incluindo produtos para olho seco, alergias oculares, glaucoma e cuidados com lentes de contato, bem como vitaminas oculares e aliviadores de vermelhidão. A empresa opera em 60 países e atende consumidores e pacientes em mais de 140 países', 'Geneva, , Switzerland', 25000);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('BMEA', 'STOCK', 'Biomea Fusion, Inc.', 'NMS', 'Healthcare', 'Biotechnology', 'Biomea Fusion, Inc. is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small molecules to improve the lives of patients with diabetes, obesity, and metabolic diseases. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company has built its proprietary FUSION System discovery platform to advance a pipeline of small molecule product candidates. Its lead clinical programs drug candidate, icovamenib, is being developed as an orally bioavailable, and selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenibs potential in type 1 and type 2 diabetes, as well as its impact in obesity. Its second product candidate BMF-650, is an investigational, oral small-molecule glucagon-like peptide-1 receptor agonists (GLP-1 RA), for the treatment of diabetes and obesity.', 'San Carlos, CA, United States', 63);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('AMZU', 'STOCK', 'Direxion Daily AMZN Bull 2X Shares', 'NGM', NULL, NULL, 'The fund will enter into one or more swap agreements with major global financial institutions whereby the fund and the global financial institution will agree to exchange the return earned on an investment by The fund invests in AMZN that is equal, on a daily basis, to 200% of the value of the fund''s net assets. It is non-diversified.', '', NULL);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('DNLI', 'STOCK', 'Denali Therapeutics Inc.', 'NMS', 'Healthcare', 'Biotechnology', 'Denali Therapeutics Inc. É uma empresa biofarmacêutica. A empresa está focada no desenvolvimento de um portfólio de candidatos a produtos projetados para cruzar a barreira hematoencefálica (BBB) para doenças neurodegenerativas e doenças de armazenamento lisossômico. A empresa possui um portfólio de medicamentos de pequena molécula e bioterapêutica, compreendendo sete candidatos a produtos em desenvolvimento clínico em sete indicações, bem como candidatos terapêuticos pré-clínicos. Seus três programas de desenvolvimento em estágio tardio incluem tividenofusp alfa (DNL310) para mucopolissacaridose II (MPS II); BIIB122/DNL151 (inibidor LRRK2) para doença de Parkinson; e DNL343 (ativador eIF2B) para esclerose lateral amiotrófica (ELA). SAR443820/DNL788 (inibidor de RIPK1) está sendo avaliado em um estudo de Fase II para esclerose múltipla (EM). Além disso, tem um estudo de Fase I/II de TAK-594/DNL593 para demência-granulina frontotemporal (FTD-GRN) e um estudo de Fase I/II de DNL126 para M', 'South San Francisco, CA, United States', 422);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('CVAC', 'STOCK', 'CureVac N.V.', 'NGM', 'Healthcare', 'Biotechnology', 'CureVac NV, formerly CureVac AG, is a Germany-based clinical-stage biopharmaceutical company. The Company develops transformative medicines based on messenger ribonucleic acid, or mRNA. The Company''s mRNAs are designed to prevent infections and to treat diseases by mimicking human biology to synthesize the desired proteins. Its technology platform optimizes mRNA constructs that encode functional proteins which either induce a desired immune response or replace defective or missing proteins using the cells intrinsic translation machinery. The Company''s product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and molecular therapy. In prophylactic vaccines, the Company is advancing its second-generation mRNA backbone against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and a range of infectious diseases, including seasonal influenza, in collaboration with GSK(Glaxo Smith Kline).', 'Tübingen, , Germany', 825);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('CHRW', 'STOCK', 'C.H. Robinson Worldwide, Inc.', 'NMS', 'Industrials', 'Integrated Freight & Logistics', 'C.H. Robinson Worldwide, Inc. É um fornecedor global de logística. Os segmentos da empresa incluem transporte de superfície norte-americano (NAST), Global Forwarding e todos os outros e corporativos. A NAST Segment fornece serviços de transporte e logística em toda a América do Norte através de uma rede de escritórios nos Estados Unidos, Canadá e México. Os serviços DA NAST Segment incluem carga de caminhão e serviços de corretagem de transporte de carga de caminhão. Global Forwarding Segment fornece serviços de transporte e logística através de uma rede internacional de escritórios na América do Norte, Europa, Ásia, Oceania, América do Sul, e o Oriente Médio e também contratos com agentes independentes em todo o mundo. Os serviços do segmento Global Forwarding incluem serviços de frete marítimo, serviços de frete aéreo e corretagem aduaneira. Todo o outro segmento e Corporate inclui Robinson Fresh e Managed Solutions. Robinson Fresh fornece serviços de sourcing. Em seu negócio de Solu', 'Eden Prairie, MN, United States', 13166);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('EBS', 'STOCK', 'Emergent BioSolutions Inc.', 'NYQ', 'Healthcare', 'Drug Manufacturers - Specialty & Generic', 'Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.', 'Gaithersburg, MD, United States', 900);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('CENX', 'STOCK', 'Century Aluminum Company', 'NMS', 'Basic Materials', 'Aluminum', 'Century Aluminum Company is a global producer of primary aluminum and operates aluminum reduction facilities, or smelters. The Company''s annual production capacity is approximately 1,020,000 tons per year (tpy). It owns a carbon anode production facility located in the Netherlands (Vlissingen). Carbon anodes are consumed in the production of primary aluminum. Vlissingen supplies carbon anodes to its aluminum smelter in Grundartangi, Iceland. Each of its aluminum smelters in the United States produces anodes at on-site facilities. Through its Natur-Al product line, it provides low-carbon aluminum products. It operates three United States aluminum smelters, in Hawesville, Kentucky (Hawesville), Robards, Kentucky (Sebree) and Goose Creek, South Carolina (Mt. Holly), and one aluminum smelter in Grundartangi, Iceland (Grundartangi). The Grundartangi facility, is an aluminum reduction facility owned and operated by the Companys wholly owned subsidiary, Nordural Grundartangi ehf.', 'Chicago, IL, United States', 2971);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('EYE', 'STOCK', 'National Vision Holdings, Inc.', 'NMS', 'Consumer Cyclical', 'Specialty Retail', 'National Vision Holdings, Inc. is an optical retail company in the United States with over 1,200 stores in 38 states and Puerto Rico. The Company operates four retail brands: America''s Best Contacts & Eyeglasses, Eyeglass World, and Vista Opticals, inside select Fred Meyer stores and on select military bases. The Company''s segment includes Owned & Host. The Company, through its subsidiary, FirstSight Vision Services, Inc., is licensed as a single-service health plan under California law and issues individual vision plans in connection with its America''s Best operations in California. It offers two products and one service, such as eyeglasses, contact lenses and eye exams. The Companys e-commerce consumer Website, DiscountContacts.com, offers a range of services to customers, including eyeglass purchasing, online scheduling and appointment reminders, contact lens purchasing, buy-in-store and ship-to-home capabilities and online frame browsing, among others.', 'Duluth, GA, United States', 13411);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('CARM', 'STOCK', 'Carisma Therapeutics, Inc.', 'NCM', 'Healthcare', 'Biotechnology', 'Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on macrophage engineering to develop transformative therapies to treat serious diseases including liver fibrosis and cancer. The Company seeks to apply the ability to engineer macrophages and monocytes, either in vivo or ex vivo. Its proprietary chimeric antigen receptor macrophages(CAR-M) platform uses CARs to redirect macrophages or monocytes against specific tumor associated antigens with the goal of targeted antitumor immunity. It is developing a pipeline of product candidates which includes CT-1119, In Vivo CAR-Macrophage: GPC3+ Solid Tumors, In Vivo CAR-Macrophage: Oncology Targets, and CT-2401 (Liver Fibrosis). CT-2401 is a product candidate in development for liver fibrosis, and CT-1119 is a mesothelin-targeted CAR-Monocyte that is designed to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothelioma, and others.', 'Philadelphia, PA, United States', 46);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('CTLP', 'STOCK', 'Cantaloupe, Inc.', 'NMS', 'Technology', 'Software - Infrastructure', 'Cantaloupe, Inc. is a global provider of technology solutions for self-service commerce. The Companys vertically integrated solutions fuel growth by offering micro-payments processing, enterprise cloud software, IoT technology, as well as kiosk and POS innovations. It offers a variety of solutions for self-service commerce, which enable the acceptance of digital payments and allow its customers to simplify inventory, analytics, warehouse, logistics, and back-office management. Its hardware includes Cantaloupe card readers, the Companys integrated payment device, as well as Cantaloupe Go POS kiosks, the Companys range of POS terminals, which are both deployed in self-service, applications, such as vending, micro-markets, amusement, air/vacuum, car wash, and others. Its Cantaloupe Go product line provides a variety of self-checkout kiosks. Its solutions are used by a variety of consumer services in the United States, the United Kingdom, European Union countries, Australia, and Mexico.', 'Malvern, PA, United States', 375);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('BWA', 'STOCK', 'BorgWarner Inc.', 'NYQ', 'Consumer Cyclical', 'Auto Parts', 'BorgWarner Inc. Está envolvida em soluções de tecnologia limpa para veículos de combustão, híbridos e elétricos. A Companhia atua em quatro segmentos. As tecnologias da Turbos & Thermal Technologies incluem turbocompressores, e-boosters, e-turbos, sistemas de emissões, sistemas térmicos, tecnologia de ignição a gasolina, atuadores remotos inteligentes, sensores do grupo motopropulsor, entre outros. Os produtos do segmento Drivetrain & Morse Systems incluem módulos de controle, produtos de embreagem mecânica e de fricção para transmissões automáticas, produtos de gerenciamento de torque e sistemas de caixa de transferência de tração traseira (RWD) e tração integral (AWD) e sistemas de acoplamento. Os produtos do segmento Powerdrive Systems incluem eletrônicos de energia, como inversores, carregadores de bordo, conversores DC/DC e caixas de combinação, entre outros. Os produtos do segmento de baterias e sistemas de carregamento incluem sistemas de baterias de iões de lítio para aplicaçõe', 'Auburn Hills, MI, United States', 38300);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('ATI', 'STOCK', 'ATI Inc.', 'NYQ', 'Industrials', 'Metal Fabrication', 'ATI Inc. is a global manufacturer of technically advanced specialty materials and complex components. The Company produces specialty materials, highly differentiated by its materials science expertise and advanced process technologies. It produces high-performance materials and solutions for the global aerospace and defense markets, and has critical applications in electronics, medical and specialty energy. The Companys segment includes High Performance Materials & Components (HPMC) and Advanced Alloys & Solutions (AA&S). The HPMC segment produces a wide range of high-performance materials, components, and advanced metallic powder alloys. These products are made from nickel-based alloys and superalloys, titanium and titanium-based alloys, and a variety of other specialty materials. The AA&S segment produces nickel-based alloys, titanium and titanium-based alloys, and specialty alloys in a variety of forms, including plate, sheet, and strip products.', 'Dallas, TX, United States', 7700);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('BAM', 'STOCK', 'Brookfield Asset Management Ltd.', 'NYQ', 'Financial Services', 'Asset Management', 'Brookfield Asset Management Ltd. is a global alternative asset manager. The Company invests client capital for the long-term with a focus on real assets and essential service businesses that form the backbone of the global economy. It offers a range of alternative investment products to investors around the world including public and private pension plans, endowments and foundations, sovereign wealth funds, financial institutions, insurance companies and private wealth investors. Its products have three categories, which include long-term private funds, permanent capital vehicles and perpetual strategies, and liquid strategies. These are invested across five principal strategies: renewable power and transition, infrastructure, real estate, private equity, and credit.', 'New York, NY, United States', 2500);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('AMGN', 'STOCK', 'Amgen Inc.', 'NMS', 'Healthcare', 'Drug Manufacturers - General', 'Amgen Inc. É uma empresa de biotecnologia. Descobre, desenvolve, fabrica e fornece medicamentos para as doenças mais difíceis. Ele se concentra em áreas de alta necessidade médica não atendida e aproveita sua expertise para buscar soluções que melhorem a vida das pessoas. Atua no segmento terapêutico humano. Seu portfólio de produtos comercializados inclui EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); Actimmune (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacina); Repatha (evolocumab) e outros. Comercializa ENBREL, um bloqueador de fatores de necrose tumoral, nos Estados Unidos e no Canadá. Comercializa Otezla, uma pequena molécula que inibe a fosfodiesterase 4, em muitos países ao redor do mundo. Comercializa o Repatha, um inibidor de subtilisina/kexin tipo 9 (PCSK9) da proproteína convert', 'Thousand Oaks, CA, United States', 28000);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('CECO', 'STOCK', 'CECO Environmental Corp.', 'NMS', 'Industrials', 'Pollution & Treatment Controls', 'CECO Environmental Corp. is an environmentally focused, diversified industrial company. The Company serves a broad landscape of industrial air, industrial water and energy transition markets globally, providing solutions and application expertise. Its Engineered System segment serves the power generation, hydrocarbon processing, water/wastewater treatment, oily water separation and treatment, marine and naval vessels, and midstream oil and gas sectors. The segment seeks to address the global demand for environmental and equipment protection solutions with its engineered platforms, including emissions management, fluid bed cyclones, thermal acoustics, separation and filtration, and dampers and expansion joints. Its Industrial Process Solutions segment serves the industrial sector with solutions for air pollution and contamination control, and process filtration in applications, such as aluminum beverage can production, automobile production, electronics production, and other markets.', 'Addison, TX, United States', 1600);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('AWK', 'STOCK', 'American Water Works Company, Inc.', 'NYQ', 'Utilities', 'Utilities - Regulated Water', 'A American Water Works Company, Inc. É uma empresa de serviços públicos de água e águas residuais. O negócio principal da Companhia envolve a propriedade de serviços públicos que fornecem serviços de água e esgoto para clientes residenciais, comerciais, industriais, de autoridade pública, de serviço de incêndio e de venda para revenda. Também opera outras empresas que fornecem serviços de água e esgoto ao governo dos Estados Unidos em instalações militares, bem como municípios. A Companhia opera seus negócios por meio do segmento de negócios regulamentados. O segmento de negócios regulamentados inclui subsidiárias que prestam serviços de água e esgoto a clientes em aproximadamente 14 estados. Os serviços públicos da empresa operam em estados como Geórgia, Havaí, Indiana, Iowa, Kentucky, Maryland, Tennessee, Virgínia e Virgínia Ocidental. A empresa também atende clientes comerciais, clientes de serviços de incêndio, clientes industriais, autoridades públicas, outros serviços públicos e ', 'Camden, NJ, United States', 6700);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('BLMN', 'STOCK', 'Bloomin'' Brands, Inc.', 'NMS', 'Consumer Cyclical', 'Restaurants', 'Bloomin Brands, Inc. is a casual dining restaurant company. It has four founder-inspired brands: Outback Steakhouse, Carrabbas Italian Grill, BonefishGrill, and Flemings Prime Steakhouse & Wine Bar. The Companys segment includes U.S. and International Franchise. Outback Steakhouse is a casual steakhouse restaurant concept focused on steaks, bold flavors and Australian decor. Carrabbas Italian Grill offers authentic Italian cuisine passed down from its founder''s family recipes. Bonefish Grill specializes in fish from around the world, hand-cut in-house every day, savory wood-grilled specialties, and locally created seasonal partner selection dishes. Flemings Prime Steakhouse & Wine Bar is a contemporary interpretation of the classic American steakhouse, boasting culinary mastery, signature style and unrivaled attentive service to create memorable dining experiences for guests. The Company owns, operates, and franchises over 1,450 restaurants in 46 states, Guam and 12 countries.', 'Tampa, FL, United States', 81000);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('ALGN', 'STOCK', 'Align Technology, Inc.', 'NMS', 'Healthcare', 'Medical Instruments & Supplies', 'A Align Technology, Inc. É uma empresa global de dispositivos médicos que projeta, fabrica e vende o sistema Invisalign de alinhadores transparentes, scanners intraorais iTero e software de design assistido por computador exocad e fabricação assistida por computador (CAD/CAM) para ortodontia digital e odontologia restaurativa. A empresa fornece a Align Digital Platform. Seus segmentos incluem Clear Aligner e Imaging Systems e CAD/CAM Services (Sistemas e Serviços). O segmento Clear Aligner consiste em produtos abrangentes, produtos não abrangentes e produtos não-Case. Seus produtos abrangentes incluem Invisalign Abrangente e Invisalign primeiro. Os produtos não-Case da Empresa incluem produtos de retenção, treinamento Invisalign e ferramentas de ajuste. Oferece até quatro conjuntos de alinhadores transparentes personalizados chamados retentores Vivera. O segmento de Sistemas e Serviços consiste em seus sistemas de escaneamento intraoral iTero. Seus serviços incluem software de assinatu', 'Tempe, AZ, United States', 21485);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('ALV', 'STOCK', 'Autoliv, Inc.', 'NYQ', 'Consumer Cyclical', 'Auto Parts', 'Autoliv, Inc. is a developer, manufacturer, and supplier of safety systems to the automotive industry with a range of product offerings, primarily passive safety systems. Passive safety systems include modules and components for frontal-impact airbag protection systems, side-impact airbag protection systems, seatbelts, steering wheels, inflator technologies and battery cut-off switches. The Company also develops and manufactures mobility safety solutions, such as pedestrian protection, battery cut-off switches, connected safety services and safety solutions for riders of powered two wheelers. The Company has one operating segment, which includes Autolivs airbag and seatbelt products and components. Its subsidiaries include Autoliv AB and Autoliv ASP, Inc. The Company operates its business in geographical regions, such as Europe, the Americas, China, Japan, and the Rest of Asia (ROA). The Company has approximately 62 production facilities in 25 countries.', 'Stockholm, , Sweden', 59241);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('ASO', 'STOCK', 'Academy Sports and Outdoors, Inc.', 'NMS', 'Consumer Cyclical', 'Specialty Retail', 'Academy Sports and Outdoors, Inc. É uma loja de artigos esportivos de linha completa e recreação ao ar livre nos Estados Unidos. A variedade de produtos da empresa está focada em categorias-chave de outdoor, vestuário, esportes e recreação, e calçados através de marcas nacionais e um portfólio de 19 marcas de marca própria. Tem acesso preferencial a marcas nacionais, como Nike, Under Armour, adidas, Winchester, etc. Columbia Sportswear, Brooks, Skechers, Yeti e Carhartt. Seu portfólio de marca de marca privada consiste em Academy Sports e Outdoor, Magellan Outdoors, BCG, O''rageous, Game Winner, Outdoor Gourmet, livremente e R.O.W. Seus principais tipos de produtos incluem refrigeradores e bebedouros, acessórios de camping e equipamentos de camping; equipamentos de fitness, acessórios de fitness e suprimentos de nutrição; vestuário exterior, vestuário sazonal, denim, vestuário de trabalho, t-shirts gráficas e acessórios; sapatos casuais, chinelos, calçado sazonal, meias; calçado para m', 'Katy, TX, United States', 22000);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('DRS', 'STOCK', 'Leonardo DRS, Inc.', 'NMS', 'Industrials', 'Aerospace & Defense', 'Leonardo DRS, Inc. is a provider of advanced defense technology to the United States national security customers and allies around the world. It specializes in the design, development and manufacture of advanced sensing, network computing, force protection, and electric power and propulsion, and other mission-critical technologies. It is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. Its segments include Advanced Sensing and Computing (ASC) and Integrated Mission Systems (IMS). The ASC segment designs, develops, and manufactures sensing and network computing technology that enables real-time situational awareness required for operational decision making and execution by its customers. The IMS segment designs, develops, manufactures, and integrates power conversion, control and distribution systems, ship propulsion systems, motors and variable frequency drives, force protection systems, transportation and logistics systems.', 'Arlington, VA, United States', 7000);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('DBRG', 'STOCK', 'DigitalBridge Group, Inc.', 'NYQ', 'Financial Services', 'Asset Management', 'DigitalBridge Group, Inc. is a global investment manager in digital infrastructure, deploying and managing capital across the digital ecosystem, including data centers, cell towers, fiber networks, small cells, and edge infrastructure. Its investment management platform is anchored by its value-added funds within the DigitalBridge Partners (DBP) infrastructure equity series. Its investment offerings also include core equity, credit and liquid securities. The DBP series of funds focuses on value-added digital infrastructure, investing in and building businesses across the digital infrastructure sector. Core Equity invests in digital infrastructure businesses and assets with long-duration cash flow profiles, primarily in more developed geographies, through its Strategic Assets Fund (SAF). DigitalBridge Credit is a private credit strategy that delivers credit solutions to corporate borrowers in the digital infrastructure sector globally through credit financing products.', 'Boca Raton, FL, United States', 309);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('CERS', 'STOCK', 'Cerus Corporation', 'NGM', 'Healthcare', 'Medical Devices', 'Cerus Corporation is a biomedical products company. The Company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.', 'Concord, CA, United States', 614);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('SGRY', 'STOCK', 'Surgery Partners, Inc.', 'NMS', 'Healthcare', 'Medical Care Facilities', 'Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility Services segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of 161 surgical facilities comprised of 142 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 200 locations in 31 states, including short-stay surgical hospitals.', 'Brentwood, TN, United States', 15000);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('BHC', 'STOCK', 'Bausch Health Companies Inc.', 'NYQ', 'Healthcare', 'Drug Manufacturers - Specialty & Generic', 'Bausch Health Companies Inc. is a global, diversified specialty pharmaceutical and medical device company. Its comprehensive portfolio of over 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter (OTC) products and ophthalmic surgical devices and instruments. The Salix segment consists of sales in the U.S. of gastroenterology products. The International segment consists of sales, except for sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Diversified segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Bausch + Lomb segment includes Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products.', 'Laval, QC, Canada', 20700);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('ARLO', 'STOCK', 'Arlo Technologies, Inc.', 'NYQ', 'Industrials', 'Building Products & Equipment', 'Arlo Technologies, Inc. is a smart home security platform company. The Company offers advanced home, business, and personal security services that combine a globally scaled cloud platform, advanced monitoring and analytics capabilities, and app-controlled devices to create a personalized security ecosystem. Its expertise in cloud services, artificial intelligence (AI) and computer vision analytics, wireless connectivity and intuitive user experience design deliver seamless, smart home security for its users. Its cloud-based platform provides users with visibility, insight and a powerful means to help protect and connect in real-time with the people and things that matter, from any location with a Wi-Fi or a cellular connection. Its products include Arlo Essential Cameras and Doorbells; Arlo Home Security System; Arlo Pro 5S; Arlo Go 2; Arlo Ultra 2; Arlo Floodlight Camera, and others. Its services include Arlo Secure, Arlo Total Security, Arlo Safe, and other services.', 'Carlsbad, CA, United States', 360);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('CIVI', 'STOCK', 'Civitas Resources, Inc.', 'NYQ', 'Energy', 'Oil & Gas E&P', 'Civitas Resources, Inc. is an independent exploration and production company. It is focused on the acquisition, development, and production of crude oil and liquids-rich natural gas from its premier assets in the DJ Basin in Colorado and the Permian Basin in Texas and New Mexico. Its development facilities are in counties across the Front Range of northern and central Colorado, and Southeastern New Mexico and West Texas. Its DJ Basin assets are comprised of over 356,800 net acres located in Weld, Arapahoe, Adams, and Boulder counties, Colorado. Its operations in the DJ Basin target the Niobrara and Codell formations. Its Permian Basin assets are comprised of over 120,400 net acres located in Upton, Reagan, Glasscock, Martin, Midland, Reeves, and Loving counties, Texas and Eddy and Lea counties, New Mexico. Its operations in the Permian Basin primarily target the Spraberry and Wolfcamp formations of the Midland Basin and the Wolfcamp and Bone Spring formations of the Delaware Basin.', 'Denver, CO, United States', 655);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('EVH', 'STOCK', 'Evolent Health, Inc.', 'NYQ', 'Healthcare', 'Health Information Services', 'Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.', 'Arlington, VA, United States', 4500);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('BALL', 'STOCK', 'Ball Corporation', 'NYQ', 'Consumer Cyclical', 'Packaging & Containers', 'A Ball Corporation (Ball) fornece soluções sustentáveis de embalagem de alumínio para clientes de bebidas, cuidados pessoais e produtos domésticos. Seus produtos de embalagem são produzidos para uma variedade de usos finais. A empresa vende seus produtos de embalagem de alumínio principalmente para grandes empresas multinacionais de bebidas, cuidados pessoais e produtos domésticos. A empresa opera em três segmentos: Embalagens de bebidas, América do Norte e Central; Embalagens de bebidas, EMEA e Embalagens de bebidas, América do Sul. O segmento de Embalagens de Bebidas, América do Norte e Central fabrica e vende recipientes de bebidas de alumínio em todos os Estados Unidos, Canadá e México. O segmento de Embalagens de Bebidas, EMEA fabrica e vende recipientes de bebidas de alumínio em vários países em toda a Europa, bem como no Egito e na Turquia. O segmento Beverage Packaging, América do Sul, fabrica e comercializa contentores de alumínio para bebidas no Brasil, Argentina, Paraguai e ', 'Westminster, CO, United States', 16000);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('ELF', 'STOCK', 'e.l.f. Beauty, Inc.', 'NYQ', 'Consumer Defensive', 'Household & Personal Products', 'e.l.f. Beauty, Inc. is a multi-brand beauty company. The Company offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skincare products. The Company''s family of brands includes e.l.f. Cosmetics, e.l.f. SKIN, Naturium, Well People and Keys Soulcare. Its e.l.f. SKIN is an ingredient-focused, dermatologist-developed formula for every eye, lip, face and skin concern. The Company operates across beauty categories including eye, lip, and face makeup, beauty tools and accessories, and skincare products. Its color cosmetics and skin care products are broadly sold through food, drug, and mass channels, as well as through department stores and direct and specialty channels. The Company''s brands are available online and across beauty, mass market and specialty retailers in the United States and internationally. The Company sell its products online through its own direct e-commerce channels, as well as through other e-commerce Websites.', 'Oakland, CA, United States', 633);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('BBIO', 'STOCK', 'BridgeBio Pharma, Inc.', 'NMS', 'Healthcare', 'Biotechnology', 'BridgeBio Pharma, Inc. is a biopharmaceutical company. It discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases. Its pipeline of development programs ranges from early science to advanced clinical trials, which includes Attruby, an oral small molecule near-complete transthyretin (TTR) stabilizer, for the treatment of cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM); Beyonttra for the treatment of TTR Amyloidosis; Low-dose Infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor (TKI) for the treatment of children with achondroplasia and hypochondroplasia; Encaleret, an oral small molecule antagonist of the calcium sensing receptor (CaSR) that it is developing for the treatment of Autosomal Dominant Hypocalcemia Type 1 (ADH1), and BBP-418, for the treatment of Limb Girdle Muscular Dystrophy Type 2I. It also conducting a Phase 1/2 study (CANaspire) for BBP-812 for Canavan disease.', 'Palo Alto, CA, United States', 725);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('BMRN', 'STOCK', 'BioMarin Pharmaceutical Inc.', 'NMS', 'Healthcare', 'Biotechnology', 'BioMarin Pharmaceutical Inc. (BioMarin) é uma empresa global de biotecnologia, que está envolvida no desenvolvimento e comercialização de terapias que abordam a causa raiz das condições genéticas. Os produtos comerciais da BioMarin incluem Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (dihidrocloreto de sapropterina) e Voxzogo (vosoritide). Vimizim é uma terapia de substituição enzimática para o tratamento de MPS IVA, um distúrbio de armazenamento lisossômico. A Roctaviana é uma terapia genética de vetor de vírus adeno associado (AAV5), projetada para restaurar as concentrações plasmáticas do fator VIII em pacientes com hemofilia grave A. Brineura é uma tripeptidil peptidase humana recombinante 1 (TPP1) para o tratamento de pacientes com CLN2, uma forma de doença de Batten. Voxzogo é um análogo de injeção diária de peptídeo natriurético tipo C (CNP) para', 'San Rafael, CA, United States', 3040);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('DOCN', 'STOCK', 'DigitalOcean Holdings, Inc.', 'NYQ', 'Technology', 'Software - Infrastructure', 'DigitalOcean Holdings, Inc. provides the simplest scalable cloud platform that democratizes cloud and AI for growing tech companies around the world. It provides a cloud computing platform, offering simple, scalable and approachable on-demand infrastructure and platform services for developers at growing technology companies. Its platform simplifies cloud computing, enabling its customers to rapidly accelerate innovation and productivity. The simplicity of its platform allows users to focus on building and scaling their business instead of on managing their infrastructure. It offers mission-critical solutions across Infrastructure-as-a-Service (IaaS), including its Droplet virtual machines, storage and networking offerings; Platform-as-a-Service and Software-as-a-Service, including its Managed Hosting, Managed Database, Managed Kubernetes and Marketplace offerings; and artificial intelligence and machine learning, including its GPU Droplets, Notebooks and GenAI Platform offerings.', 'New York, NY, United States', 1210);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('ED', 'STOCK', 'Consolidated Edison, Inc.', 'NYQ', 'Utilities', 'Utilities - Regulated Electric', 'A Edison, Inc. É uma empresa de fornecimento de energia. A Companhia, através de suas subsidiárias, Consolidated Edison Company of New York, Inc. (CECONY), Orange and Rockland Utilities, Inc. (O&R) e Con Edison Transmission, Inc., fornece uma gama de produtos e serviços relacionados à energia para seus clientes. CECONY é uma concessionária regulamentada que fornece serviço elétrico na cidade de Nova York e Westchester County, em Nova York, serviço de gás em Manhattan, no Bronx, partes de Queens e partes de Westchester, e serviço de vapor em Manhattan. A O&R e a sua subsidiária de serviços públicos, a Rockland Electric Company, prestam serviços elétricos a clientes no sudeste de Nova Iorque e no norte de Nova Jersey, uma área de serviço de 1 300 milhas quadradas. O&R entrega gás aos clientes no sudeste de Nova Iorque. A Conn Edison Transmission, Inc. É responsável principalmente pela supervisão da Federal Energy Regulatory Commission e gerencia, através de joint ventures, ativos elétric', 'New York, NY, United States', 15097);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('CDNA', 'STOCK', 'CareDx, Inc', 'NGM', 'Healthcare', 'Diagnostics & Research', 'CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.', 'South San Francisco, CA, United States', 644);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('BILL', 'STOCK', 'BILL Holdings, Inc.', 'NYQ', 'Technology', 'Software - Application', 'A Bill Holdings, Inc. Fornece uma plataforma de operações financeiras para pequenas e médias empresas (PMEs). A empresa oferece software como serviço, pagamentos baseados na nuvem e produtos de gerenciamento de gastos e despesas, que permitem aos usuários automatizar transações de contas a pagar e contas a receber, permitir que as empresas se conetem facilmente com seus fornecedores e/ou clientes para fazer negócios, eliminar relatórios de despesas, gerenciar fluxos de caixa e melhorar a eficiência do back-office. Sua plataforma de software financeiro habilitada para inteligência artificial (IA) cria conexões perfeitas entre seus clientes, seus fornecedores e seus clientes. As empresas em sua plataforma geram e processam faturas, agilizam aprovações, fazem e recebem pagamentos, gerenciam despesas de funcionários, sincronizam com seu sistema de contabilidade, promovem a colaboração e gerenciam seu fluxo de caixa. Sua plataforma integrada também inclui gastos e despesas DE CONTAS, seu pr', 'San Jose, CA, United States', 2187);\n
INSERT INTO assets_master (ticker, asset_type, name, exchange, sector, industry, business_description, headquarters, employees_count) VALUES ('CADL', 'STOCK', 'Candel Therapeutics, Inc.', 'NGM', 'Healthcare', 'Biotechnology', 'Candel Therapeutics, Inc. is a BLA-ready clinical-stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic antitumor immune response to help patients fight cancer. CAN-2409 is the lead product candidate from the adenovirus platform. CAN-3110 is the lead product candidate from the herpes simplex virus (HSV) platform and is in an ongoing phase Ib clinical trial in recurrent high-grade glioma. Its enLIGHTEN Discovery Platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. CAN-2409, Its advanced multimodal biological immunotherapy candidate, is an investigational, off-the-shelf, replication-defective adenovirus engineered to deliver the herpes simplex virus thymidine kinase (HSV-tk) gene to a patients specific tumor and induce an individualized, systemic immune response against the tumor.', 'Needham, MA, United States', 38);\n
